KEVIN FISHER to Proto-Oncogene Proteins B-raf
This is a "connection" page, showing publications KEVIN FISHER has written about Proto-Oncogene Proteins B-raf.
Connection Strength
1.809
-
BRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply. Hum Pathol. 2015 Jul; 46(7):1065-6.
Score: 0.409
-
Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies. Appl Immunohistochem Mol Morphol. 2014 Sep; 22(8):562-7.
Score: 0.392
-
Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Hum Pathol. 2014 Nov; 45(11):2281-93.
Score: 0.391
-
BRAF V600E-positive mononuclear cells in blood at diagnosis portend treatment failure and neurodegeneration in pediatric LCH. Blood. 2025 Jul 10; 146(2):206-218.
Score: 0.208
-
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol. 2018 Feb; 36(1):307-315.
Score: 0.116
-
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. Mol Cell. 2015 Aug 06; 59(3):345-358.
Score: 0.104
-
BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression. Appl Immunohistochem Mol Morphol. 2014 Oct; 22(9):648-51.
Score: 0.099
-
Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma. J Surg Res. 2013 Nov; 185(1):217-24.
Score: 0.090